Skip to main content
. 2018 May 29;5(2):193–203. doi: 10.3233/JND-170225

Table 2.

Respiratory dysfunction

Total BMD IMD
n % n % n %
FVC (%) 60 75.9 48.5 +/–20.9 31 88.6 59.2 +/–14.8 29 65.9 36.4 +/–17.3
(50.8, 5.9–80.4) (59.9, 14.0–80.4) (37.0. 5.9–63.0)
no FVC data 19 24.1 4 11.3 15 34.1
ambulation
  ambulant 17 21.5 17 48.6 0 0.0
  non-ambulant 62 78.5 18 51.4 44 100.0
  age at loss of ambulation (y.o.) 63 79.7 18.9 +/–11.2 18 51.4 29.4 +/–5.6 44 100.0 14.0 +/–1.0
(14, 13–65) (20, 17–65) (14, 13–16)
Steroid
  never 58 73.4 28 80.0 30 68.2
  current 11 13.9 4 11.4 7 15.9
  former 10 12.7 3 8.6 7 15.9
cardiac function
  dysfunction 53 67.1 19 54.3 34 77.3
  normal 26 32.9 16 45.7 10 22.7
genotyping
  in-frame 28 35.4 19 54.3 9 20.5
  out-of-frame 35 44.3 6 17.1 29 65.9
  Small mutation 16 20.3 10 28.6 6 13.6
IHC
  faint and patchy 11 13.9 5 14.3 5 11.4
  negative 10 12.7 4 11.4 7 15.9
  no data 58 73.4 26 74.3 32 72.7